Aptiv

APTV on NYSE. Aptiv sells vehicle parts and software to automakers. Market value $9.1bn.

Watch this stockFree. We tell you when something changes.

Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.

Should I look at this?

Worth a closer look

Read what could go wrong

This is not advice. Check the numbers below.

Compare with another stock

Cash yield
annual report to December 2025
16.5%very high

For every $100 of what the whole company costs, it produced $16.47 of spare cash last year. A savings account pays about $4.

Price to profit
annual report to December 2025
11.7×fair

You pay 11.7 years of operating profit for the business. The average large US company costs around 18.

Return on capital
five annual reports to December 2025
7.6%five-year median

Each dollar kept in the business earns 8 cents a year. Above 10 is good.

Quality score: 80 of 100. Price score: 79 of 100. Our list needs 70 on quality and 60 on price.

$44.72 a share, 5% above its 1-year low

Over the past year the price has ranged from $42.56 to $88.93.

Pays no dividend

Prices from Tuesday’s close (6 October).

Five years of cash, in billions

0.6
0.4
1.0
1.6
1.5
20212022202320242025
Revenue
$15.6bn$17.5bn$20.1bn$19.7bn$20.4bn
Operating margin
7.6%7.2%7.8%9.3%5.8%
Debt to equity
0.490.740.541.020.82
Shares outstanding
0.27bn0.28bn0.24bn0.22bn0.21bn

Health checks

  • Free cash flow positive5 of 5 years
  • Accounting looks honest (Beneish)Nothing unusual
  • Financial strength (Piotroski)9 of 9
  • Profit backed by cash (accruals)Yes
  • Debt0.82× equity
  • Revenue growth, five yearsSlow, 9.3% a year
  • Buying back its own sharesYes, 23% fewer since 2021

The quarter to June 2026

How the business did, compared with the same quarter a year earlier.

  • Sales: $3.3 billion last quarter, up 2% on a year ago.
  • Profit: $248 million, down 37% on a year ago.
  • 3% fewer shares than a year ago. Each share owns a bit more of the company.
  • Debt is $4.6 billion more than cash, down from $6.3 billion a year ago.
  • Sales grew on a year ago in each of the last 4 quarters.
Sales by quarter
Sales by quarter
Quarter toAmount
September 2024$4.9bn
December 2024$4.9bn
March 2025$4.8bn
June 2025$3.2bn
September 2025$5.2bn
December 2025$5.2bn
March 2026$5.1bn
June 2026$3.3bn
Profit by quarter
Profit by quarter
Quarter toAmount
September 2024$363m
December 2024$268m
March 2025-$11m
June 2025$393m
September 2025-$355m
December 2025$138m
March 2026$189m
June 2026$248m

From the company's quarterly reports to the SEC.

Dates

Next results (estimated)
29 October 2026
Last annual report (10-K)
6 February 2026
Next quarterly (estimated, 10-Q)
3 November 2026

Who owns it

10 long-term investors we follow own it, down from 12 last quarter. 660 funds in all.

Jun '25
Dec '25
Jun '26
Largest holders overall

From 13F filings for the quarter ended 30 June 2026.

Big holders and activists

2 investors own more than 5%.

From Schedule 13D and 13G filings: anyone owning more than 5% must file one.

What insiders did

In the last 12 months, 4 insiders bought $9m of shares on the open market. 4 sold $4m, $4m of it under preset trading plans.

Cluster buy4 insiders bought within 30 days (5 August 2026 to 13 August 2026).
  • Agnevall Hakan
    Director
    Bought
    Date
    13 August 2026
    Shares
    4,100
    Price
    $48.58
    Value
    $199,182
  • Mahoney Sean O
    Director
    Bought
    Date
    11 August 2026
    Shares
    11,000
    Price
    $50.24
    Value
    $552,683
  • CLARK KEVIN P
    Chair and CEO, Director
    Bought
    Date
    10 August 2026
    Shares
    51,190
    Price
    $48.89
    Value
    $3m
  • MEISTER PAUL M
    Director
    Bought
    Date
    5 August 2026
    Shares
    105,631
    Price
    $47.33
    Value
    $5m
  • Louissaint Obed D.
    EVP & Chief People Officer
    Sold
    under a preset trading plan
    Date
    15 June 2026
    Shares
    3,000
    Price
    $69.60
    Value
    $208,800
  • Ramundo Katherine H
    EVP, CLO, CCO & Secretary
    Sold
    under a preset trading plan
    Date
    3 June 2026
    Shares
    2,000
    Price
    $78.30
    Value
    $156,600
  • Agnevall Hakan
    Director
    Bought
    Date
    8 May 2026
    Shares
    6,100
    Price
    $57.73
    Value
    $352,153
  • Ramundo Katherine H
    EVP, CLO, CCO & Secretary
    Sold
    under a preset trading plan
    Date
    8 January 2026
    Shares
    5,000
    Price
    $85.00
    Value
    $425,000
  • Laroyia Varun
    EVP & Chief Financial Officer
    Sold
    under a preset trading plan
    Date
    12 December 2025
    Shares
    5,000
    Price
    $80.05
    Value
    $400,250
  • Agnevall Hakan
    Director
    Bought
    Date
    12 December 2025
    Shares
    3,700
    Price
    $80.25
    Value
    $296,925

From Form 4 filings: insiders must report trades in their own company's shares within two days.

Warning signs in its filings

Problems the company itself reported to the SEC, in its own words.

None of the warning signs we check for were found.

We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.

We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 6 Feb 2026, plus the 10-Q filed 4 Aug 2026 and 15 later 8-Ks.

A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.

What could go wrong

Cheap for a reason is the question the numbers cannot answer.

Whether the price already reflects the risks is what the deep dive is for.

What changed in the risks this year

Companies must list what could hurt them each year. These are the parts that changed since last year’s report.

  • If our distribution of the shares of Versigent to our shareholders fails to qualify as tax-free for U.S. federal income tax purposes, certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities.

    Could happen
    We intend to enter into a tax matters agreement with Versigent, under which Versigent will make certain representations and covenants intended to protect the tax-free treatment of the Separation and certain related transactions (the “Tax Matters Agreement”). If, as a result of any of those representations being untrue or those covenants being breached, the Separation and/or certain related transactions were determined not to qualify for non-recognition of gain or loss under Section 355 and related provisions of the Code, Versigent could be required by the Tax Matters Agreement to indemnify us for the resulting taxes and related expenses. However, if Versigent fails to satisfy its indemnification obligations to us in respect of such taxes and expenses, our business, financial condition, cash flows and results of operations could be adversely affected.
    Read more
  • If our distribution of the shares of Versigent to our shareholders fails to qualify as tax-free for U.S. federal income tax purposes, certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities.

    Could happen
    In addition, the opinions of our tax advisors will rely on certain facts, assumptions, representations, and undertakings from Versigent and us regarding the past and future conduct of the companies’ respective businesses and other matters and will be subject to certain caveats. If any of these facts, assumptions, representations, or undertakings are, or become, inaccurate or incomplete or are not otherwise satisfied, we and our shareholders may not be able to rely on the opinions of our tax advisors, and certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities. The opinions of our tax advisors will represent the judgment of each tax advisor, respectively, and will not be binding on the IRS or any courts, and there can be no assurance that the IRS will not take a contrary position or that a court will not uphold such position taken by the IRS. Notwithstanding the opinions of our tax advisors, the IRS could determine on audit that the Separation and/or certain related transactions are taxable if it determines that any of these facts, assumptions, representations, or undertakings are not correct or have been violated or if it disagrees with the conclusions in the opinion, or for other reasons, including as a result of certain significant changes in the share ownership of Versigent or us after the Separation. If the conclusions expressed in the opinions of our tax advisors are challenged by the IRS, and if the IRS prevails in such challenge, the tax consequences of the Separation (including the tax consequences to certain of our subsidiaries and our U.S. Holders) could be materially less favorable.
    Read more
  • If our distribution of the shares of Versigent to our shareholders fails to qualify as tax-free for U.S. federal income tax purposes, certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities.

    Could happen
    If the Separation and/or certain related transactions were determined not to qualify for non-recognition of gain or loss under Section 355 and related provisions of the Code, each U.S. Holder who received ordinary shares of Versigent in the Separation would be treated as having received a distribution in an amount equal to the fair market value of such ordinary shares received, which would generally result in: (i) a taxable dividend to the U.S. Holder to the extent of that U.S. Holder’s pro rata share of our current or accumulated earnings and profits; (ii) a reduction in the U.S. Holder’s basis (but not below zero) in our ordinary shares; and (iii) taxable gain from the exchange of our ordinary shares to the extent the amount received exceeds the sum of the U.S. Holder’s share of our earnings and profits and the U.S. Holder’s basis in our ordinary shares.
    Read more
  • If our distribution of the shares of Versigent to our shareholders fails to qualify as tax-free for U.S. federal income tax purposes, certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities.

    Could happen
    In addition, certain of our subsidiaries could be subject to U.S. federal income tax if the Separation and/or certain related transactions were determined not to qualify for non-recognition under Section 355 and related provisions of the Code. These amounts could be material, and could adversely affect our business, financial conditions, cash flows and results of operations.
    Read more
  • If our distribution of the shares of Versigent to our shareholders fails to qualify as tax-free for U.S. federal income tax purposes, certain of our subsidiaries and our U.S. shareholders could be subject to significant tax liabilities.

    Could happen
    It is a condition to the distribution of the shares of Versigent to our shareholders as part of the Separation that we receive one or more tax opinions from our tax advisors, satisfactory to our Board of Directors in its sole discretion, regarding the qualification of the Separation as a distribution under Section 355(a)(1) of the Internal Revenue Code of 1986, as amended (the “Code”). We do not intend to seek a ruling from the Internal Revenue Service (the “IRS”) with respect to the U.S. federal income tax treatment of the Separation. The opinions of our tax advisors will assume that the Separation will be completed according to the terms of a separation and distribution agreement that we intend to enter into with Versigent prior to the Separation (the “Separation and Distribution Agreement”) and relies on the facts as stated in the Separation and Distribution Agreement, the Tax Matters Agreement (as defined below) and a number of other documents.
    Read more

Read it in the annual report

The deep dive

Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.

  • What the business is worth, as a range, and the margin of safety at today’s price
  • Prices to start buying, buy, and buy hard
  • The three things that would make this a mistake
  • Every number footnoted to the filing it came from

It's near its lowest price in a year. The deep dive tells you if that's a bargain or a warning.

Create a free account to run it

Your first deep dive is free.

What a finished deep dive looks like

Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.